According to Future Market Insights (FMI), the global cerebral oximetry monitoring market is set to experience robust growth, with its value expected to reach USD 217.24 million in 2023 and more than double to USD 435.40 million by 2033, representing a 7.2% compound annual growth rate (CAGR) over the next decade.
Technological advancements continue to drive the evolution of cerebral oximeters, which are increasingly utilized in therapeutic settings such as vascular and cardiac surgeries. These devices feature an oximeter probe with a cable attachment connected to a monitor, providing continuous, non-invasive readings of brain oxygenation levels. Notably, Near-Infrared Spectroscopy (NIRS) technology has become a key component of these devices, offering real-time insights into the brain’s oxygen supply, which is essential for anesthesia regulation and overall brain health.
The growing incidence of neurological disorders, coupled with an aging global population, is anticipated to drive the rising demand for non-invasive monitoring solutions. In particular, the increasing approval and use of cerebral oximeters by the U.S. Food and Drug Administration (FDA) presents a significant opportunity for industry players to expand their offerings. As hospitals and healthcare systems focus more on continuous, accurate monitoring to manage patient care, cerebral oximetry is emerging as a critical tool in both routine and complex medical procedures.
North America, home to a highly developed medical device sector, continues to lead the global cerebral oximetry monitoring market. The region’s dominance is fueled by its advanced healthcare infrastructure, increasing demand for high-quality care, and favorable reimbursement policies. Moreover, the presence of key industry players in North America has further bolstered the market, setting the stage for continued growth and innovation in the years ahead.
“Cerebral oximetry monitoring devices play a vital role in ensuring the brain receives adequate oxygen, particularly during critical surgeries and in the management of neurological diseases,” said an FMI industry expert. “As the market for these devices expands, innovations in technology and favorable market conditions are expected to significantly contribute to their widespread adoption.”
With the global rise in neurological diseases and a stronger emphasis on patient-centric healthcare solutions, the cerebral oximetry monitoring market is poised for substantial growth in the coming years.
Key Takeaways:
- Given the increasing demand for non-invasive brain function monitoring and technological improvements, the United States cerebral oximetry monitoring market is anticipated to rise steadily.
- Owing to the growing occurrence of neurological disorders and the expanding use of cerebral oximetry monitoring in surgical operations, the market in the United Kingdom is predicted to expand.
- Given the increasing prevalence of cerebrovascular illnesses and the growing emphasis on improving patient outcomes through real-time brain function monitoring during operations, the market in China is predicted to experience substantial development.
- Owing to an aging population and an increase in the frequency of brain and cardiovascular disorders, the market is estimated to be growing consistently in Japan.
Enhanced Interest in Market Trends: Access In-Depth Analysis and Insights with Our Full Report!
Competitive Landscape:
Manufacturers in the cerebral oximetry monitoring market are concentrating on creating cutting-edge technologies and devices that offer precise and immediate monitoring of the levels of oxygenation in the brain. To increase the efficacy and efficiency of these items, they are also making investments in research and development. To broaden their market reach and enhance patient outcomes, manufacturers are also working with healthcare professionals and increasing their distribution networks.
Recent Developments:
- Masimo reported that O3 Regional Oximetry was given FDA approval for extended usage in August 2020. This included monitoring changes in hemoglobin, oxy-hemoglobin, and deoxy-hemoglobin in adult brains as well as somatic tissue oxygenation saturation in all patient groups.
- The NellcorTM Bedside Respiratory Patient Monitoring system was introduced by Medtronic in 2021. Clinicians can immediately identify and respond to respiratory distress owing to the system’s continuous monitoring of patients’ oxygenation and respiratory status.
Key Players:
- Masimo
- GE Healthcare
- Medtronic
- Nonin
- Mespere LifeSciences
- Edwards Lifesciences Corporation
- ISS, Inc.
- Hamamatsu Photonics K.K.
- Terumo Cardiovascular Systems Corporation
Cerebral Oximetry Monitoring Market Segmentation:
Cerebral Oximetry Monitoring Industry By Application:
- Cerebral Oximetry Monitoring for Cardiac Surgery
- Cerebral Oximetry Monitoring for Vascular Surgery
- Cerebral Oximetry Monitoring for Others
Cerebral Oximetry Monitoring Industry By Age Group:
- Cerebral Oximetry Monitoring for Pediatric
- Cerebral Oximetry Monitoring for Adult
Cerebral Oximetry Monitoring Industry By End User:
- Cerebral Oximetry Monitoring for Hospitals & Clinics
- Cerebral Oximetry Monitoring for Ambulatory Surgical Centers
- Cerebral Oximetry Monitoring for Others
Cerebral Oximetry Monitoring Industry By Region:
- Cerebral Oximetry Monitoring in North America Market
- Cerebral Oximetry Monitoring in Europe Market
- Cerebral Oximetry Monitoring in Asia Pacific Market
- Cerebral Oximetry Monitoring in Latin America Market
- Cerebral Oximetry Monitoring in the Middle East & Africa Market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube